Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/ZBIO/Capital expenditures

Zenas BioPharma, Inc. (ZBIO) Capital expenditures 2023–2025

Zenas BioPharma, Inc. (ZBIO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$18,000FY2025 · since FY2023: $17,000 → $18,000
232425
Fiscal yearValueYoY
FY2025$18,000-86.3%
FY2024$131,000+670.6%
FY2023$17,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More ZBIO financial trends

ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Operating cash flowZBIO Free cash flowZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →